BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22309470)

  • 1. Enhancing the effectiveness of juvenile drug courts by integrating evidence-based practices.
    Henggeler SW; McCart MR; Cunningham PB; Chapman JE
    J Consult Clin Psychol; 2012 Apr; 80(2):264-75. PubMed ID: 22309470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System-level effects of integrating a promising treatment into juvenile drug courts.
    McCart MR; Henggeler SW; Chapman JE; Cunningham PB
    J Subst Abuse Treat; 2012 Sep; 43(2):231-43. PubMed ID: 22154039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of family therapy in juvenile drug court.
    Dakof GA; Henderson CE; Rowe CL; Boustani M; Greenbaum PE; Wang W; Hawes S; Linares C; Liddle HA
    J Fam Psychol; 2015 Apr; 29(2):232-41. PubMed ID: 25621927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders.
    Henggeler SW; Clingempeel WG; Brondino MJ; Pickrel SG
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):868-74. PubMed ID: 12108813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments.
    Henggeler SW; Halliday-Boykins CA; Cunningham PB; Randall J; Shapiro SB; Chapman JE
    J Consult Clin Psychol; 2006 Feb; 74(1):42-54. PubMed ID: 16551142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental Health Referrals Reduce Recidivism in First-Time Juvenile Offenders, But How Do We Determine Who is Referred?
    Zeola MP; Guina J; Nahhas RW
    Psychiatr Q; 2017 Mar; 88(1):167-183. PubMed ID: 27241528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mental health and substance use problems and criminogenic risk on outcomes in serious juvenile offenders.
    Schubert CA; Mulvey EP; Glasheen C
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):925-37. PubMed ID: 21871374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between juvenile offenders with and without substance use problems in the prevalence and impact of risk and protective factors for criminal recidivism.
    van der Put CE; Creemers HE; Hoeve M
    Drug Alcohol Depend; 2014 Jan; 134():267-274. PubMed ID: 24238911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cumulative Substance Use Score as a Novel Measure to Predict Risk of Criminal Recidivism in Forensic Juvenile Male Outpatients.
    Aebi M; Bessler C; Steinhausen HC
    Child Psychiatry Hum Dev; 2021 Feb; 52(1):30-40. PubMed ID: 32246360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six years on: a prospective cohort study of male juvenile offenders in secure care.
    Chitsabesan P; Rothwell J; Kenning C; Law H; Carter L; Bailey S; Clark A
    Eur Child Adolesc Psychiatry; 2012 Jun; 21(6):339-47. PubMed ID: 22427059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Police-registered offenses and psychiatric disorders among young males : the Finnish "From a boy to a man" birth cohort study.
    Elonheimo H; Niemelä S; Parkkola K; Multimäki P; Helenius H; Nuutila AM; Sourander A
    Soc Psychiatry Psychiatr Epidemiol; 2007 Jun; 42(6):477-84. PubMed ID: 17450452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering more effective treatment to adolescents: Improving the juvenile drug court model.
    Belenko S; Logan TK
    J Subst Abuse Treat; 2003 Oct; 25(3):189-211. PubMed ID: 14670524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Religiosity, Crime, and Drug Use Among Juvenile Offenders: A Test of Reciprocal Relationships Over Time.
    Jang SJ
    Int J Offender Ther Comp Criminol; 2018 Oct; 62(14):4445-4464. PubMed ID: 29749264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system.
    Peters RH; Young MS; Rojas EC; Gorey CM
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):475-488. PubMed ID: 28375656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial adversity, delinquent pathway and internalizing psychopathology in juvenile male offenders.
    Lemos I; Faísca L
    Int J Law Psychiatry; 2015; 42-43():49-57. PubMed ID: 26299601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a family-based HIV prevention intervention for substance using juvenile offenders.
    Tolou-Shams M; Dauria E; Conrad SM; Kemp K; Johnson S; Brown LK
    J Subst Abuse Treat; 2017 Jun; 77():115-125. PubMed ID: 28476263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile drug courts: emerging outcomes and key research issues.
    Henggeler SW
    Curr Opin Psychiatry; 2007 May; 20(3):242-6. PubMed ID: 17415076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the differential costs of criminal activity for juvenile drug court participants: challenges and recommendations.
    McCollister KE; French MT; Sheidow AJ; Henggeler SW; Halliday-Boykins CA
    J Behav Health Serv Res; 2009 Jan; 36(1):111-26. PubMed ID: 18172769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organizational structure, climate, and collaboration between juvenile justice and community mental health centers: implications for evidence-based practice implementation for adolescent substance use disorder treatment.
    Johnson-Kwochka A; Dir A; Salyers MP; Aalsma MC
    BMC Health Serv Res; 2020 Oct; 20(1):929. PubMed ID: 33032587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile Drug Treatment Court.
    Ledgerwood DM; Cunningham PB
    Pediatr Clin North Am; 2019 Dec; 66(6):1193-1202. PubMed ID: 31679607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.